A novel adenoviral gutless vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model

Jae Ung Lee, Jinho Shin, Woohyuk Song, Hyunjoong Kim, Seunghwan Lee, Se Jin Jang, S. Chiu Wong, Jay E. Edelberg, Gene Liau, Mun K. Hong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: We previously demonstrated that sphingosine kinase (SPK) increases the level of extracellular sphingosine-1-phosphate and promotes neovascularization in a mouse matrigel model. In this study, we tested the hypothesis that SPK gene transfer using a novel adenoviral 'gutless' vector (AGV) can enhance arteriogenesis in a rabbit hindlimb ischemia model. Methods: Thirty-five male New Zealand white rabbits were randomized to the AGV-SPK group (n = 13), AGV-null group (n = 13), and control group (n = 9). On day 10, after the induction of unilateral hindlimb ischemia, gene vectors or buffer were introduced and the effect examined on day 30, using calf blood pressure, quantitative angiographic analysis, and histology. Results: Calf systolic blood pressure ratios of the ischemic limb to the normal limb on day 30 were 0.77 ± 0.13 in control groups, including the AGV-null group, and 0.91 ± 0.14 in the AGV-SPK group (P < 0.05). Angiographic vessel counts were significantly increased (8.0 ± 2.1 at baseline and 11.8 ± 3.2 on day 30, P < 0.001) in the AGV-SPK group. Histologic analysis showed that microscopic total vessel counts on day 30 were 3.5 ± 1.8/field in the control and AGV-null group and 5.4 ± 1.0/field in the AGV-SPK group. Arterioles (AGV-SPK; 3.0 ± 0.8 versus control and AGV-null; 2.1 ± 1.1, P < 0.05) were significantly increased in the AGV-SPK group. Conclusions: This study shows that SPK promotes arteriogenesis, as evidenced by the maximal improvement in the blood pressure restoration and collateral vessel counts. SPK may be an important angiogenic target to improve perfusion in ischemic tissues.

Original languageEnglish
Pages (from-to)451-456
Number of pages6
JournalCoronary Artery Disease
Volume16
Issue number7
DOIs
Publication statusPublished - 2005 Nov 1
Externally publishedYes

Fingerprint

Hindlimb
Ischemia
Perfusion
Rabbits
Blood Pressure
Extremities
sphingosine kinase
Control Groups
Arterioles
Genes
Histology
Buffers

Keywords

  • Angiogenesis
  • Arteriogenesis
  • Coronary artery disease
  • Gene therapy
  • Rabbit hindlimb ischemia model

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

A novel adenoviral gutless vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model. / Lee, Jae Ung; Shin, Jinho; Song, Woohyuk; Kim, Hyunjoong; Lee, Seunghwan; Jang, Se Jin; Wong, S. Chiu; Edelberg, Jay E.; Liau, Gene; Hong, Mun K.

In: Coronary Artery Disease, Vol. 16, No. 7, 01.11.2005, p. 451-456.

Research output: Contribution to journalArticle

Lee, Jae Ung ; Shin, Jinho ; Song, Woohyuk ; Kim, Hyunjoong ; Lee, Seunghwan ; Jang, Se Jin ; Wong, S. Chiu ; Edelberg, Jay E. ; Liau, Gene ; Hong, Mun K. / A novel adenoviral gutless vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model. In: Coronary Artery Disease. 2005 ; Vol. 16, No. 7. pp. 451-456.
@article{25975927f6d4409698342d4c9c12ffb2,
title = "A novel adenoviral gutless vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model",
abstract = "Objectives: We previously demonstrated that sphingosine kinase (SPK) increases the level of extracellular sphingosine-1-phosphate and promotes neovascularization in a mouse matrigel model. In this study, we tested the hypothesis that SPK gene transfer using a novel adenoviral 'gutless' vector (AGV) can enhance arteriogenesis in a rabbit hindlimb ischemia model. Methods: Thirty-five male New Zealand white rabbits were randomized to the AGV-SPK group (n = 13), AGV-null group (n = 13), and control group (n = 9). On day 10, after the induction of unilateral hindlimb ischemia, gene vectors or buffer were introduced and the effect examined on day 30, using calf blood pressure, quantitative angiographic analysis, and histology. Results: Calf systolic blood pressure ratios of the ischemic limb to the normal limb on day 30 were 0.77 ± 0.13 in control groups, including the AGV-null group, and 0.91 ± 0.14 in the AGV-SPK group (P < 0.05). Angiographic vessel counts were significantly increased (8.0 ± 2.1 at baseline and 11.8 ± 3.2 on day 30, P < 0.001) in the AGV-SPK group. Histologic analysis showed that microscopic total vessel counts on day 30 were 3.5 ± 1.8/field in the control and AGV-null group and 5.4 ± 1.0/field in the AGV-SPK group. Arterioles (AGV-SPK; 3.0 ± 0.8 versus control and AGV-null; 2.1 ± 1.1, P < 0.05) were significantly increased in the AGV-SPK group. Conclusions: This study shows that SPK promotes arteriogenesis, as evidenced by the maximal improvement in the blood pressure restoration and collateral vessel counts. SPK may be an important angiogenic target to improve perfusion in ischemic tissues.",
keywords = "Angiogenesis, Arteriogenesis, Coronary artery disease, Gene therapy, Rabbit hindlimb ischemia model",
author = "Lee, {Jae Ung} and Jinho Shin and Woohyuk Song and Hyunjoong Kim and Seunghwan Lee and Jang, {Se Jin} and Wong, {S. Chiu} and Edelberg, {Jay E.} and Gene Liau and Hong, {Mun K.}",
year = "2005",
month = "11",
day = "1",
doi = "10.1097/00019501-200510000-00006",
language = "English",
volume = "16",
pages = "451--456",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - A novel adenoviral gutless vector encoding sphingosine kinase promotes arteriogenesis and improves perfusion in a rabbit hindlimb ischemia model

AU - Lee, Jae Ung

AU - Shin, Jinho

AU - Song, Woohyuk

AU - Kim, Hyunjoong

AU - Lee, Seunghwan

AU - Jang, Se Jin

AU - Wong, S. Chiu

AU - Edelberg, Jay E.

AU - Liau, Gene

AU - Hong, Mun K.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Objectives: We previously demonstrated that sphingosine kinase (SPK) increases the level of extracellular sphingosine-1-phosphate and promotes neovascularization in a mouse matrigel model. In this study, we tested the hypothesis that SPK gene transfer using a novel adenoviral 'gutless' vector (AGV) can enhance arteriogenesis in a rabbit hindlimb ischemia model. Methods: Thirty-five male New Zealand white rabbits were randomized to the AGV-SPK group (n = 13), AGV-null group (n = 13), and control group (n = 9). On day 10, after the induction of unilateral hindlimb ischemia, gene vectors or buffer were introduced and the effect examined on day 30, using calf blood pressure, quantitative angiographic analysis, and histology. Results: Calf systolic blood pressure ratios of the ischemic limb to the normal limb on day 30 were 0.77 ± 0.13 in control groups, including the AGV-null group, and 0.91 ± 0.14 in the AGV-SPK group (P < 0.05). Angiographic vessel counts were significantly increased (8.0 ± 2.1 at baseline and 11.8 ± 3.2 on day 30, P < 0.001) in the AGV-SPK group. Histologic analysis showed that microscopic total vessel counts on day 30 were 3.5 ± 1.8/field in the control and AGV-null group and 5.4 ± 1.0/field in the AGV-SPK group. Arterioles (AGV-SPK; 3.0 ± 0.8 versus control and AGV-null; 2.1 ± 1.1, P < 0.05) were significantly increased in the AGV-SPK group. Conclusions: This study shows that SPK promotes arteriogenesis, as evidenced by the maximal improvement in the blood pressure restoration and collateral vessel counts. SPK may be an important angiogenic target to improve perfusion in ischemic tissues.

AB - Objectives: We previously demonstrated that sphingosine kinase (SPK) increases the level of extracellular sphingosine-1-phosphate and promotes neovascularization in a mouse matrigel model. In this study, we tested the hypothesis that SPK gene transfer using a novel adenoviral 'gutless' vector (AGV) can enhance arteriogenesis in a rabbit hindlimb ischemia model. Methods: Thirty-five male New Zealand white rabbits were randomized to the AGV-SPK group (n = 13), AGV-null group (n = 13), and control group (n = 9). On day 10, after the induction of unilateral hindlimb ischemia, gene vectors or buffer were introduced and the effect examined on day 30, using calf blood pressure, quantitative angiographic analysis, and histology. Results: Calf systolic blood pressure ratios of the ischemic limb to the normal limb on day 30 were 0.77 ± 0.13 in control groups, including the AGV-null group, and 0.91 ± 0.14 in the AGV-SPK group (P < 0.05). Angiographic vessel counts were significantly increased (8.0 ± 2.1 at baseline and 11.8 ± 3.2 on day 30, P < 0.001) in the AGV-SPK group. Histologic analysis showed that microscopic total vessel counts on day 30 were 3.5 ± 1.8/field in the control and AGV-null group and 5.4 ± 1.0/field in the AGV-SPK group. Arterioles (AGV-SPK; 3.0 ± 0.8 versus control and AGV-null; 2.1 ± 1.1, P < 0.05) were significantly increased in the AGV-SPK group. Conclusions: This study shows that SPK promotes arteriogenesis, as evidenced by the maximal improvement in the blood pressure restoration and collateral vessel counts. SPK may be an important angiogenic target to improve perfusion in ischemic tissues.

KW - Angiogenesis

KW - Arteriogenesis

KW - Coronary artery disease

KW - Gene therapy

KW - Rabbit hindlimb ischemia model

UR - http://www.scopus.com/inward/record.url?scp=27344433839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27344433839&partnerID=8YFLogxK

U2 - 10.1097/00019501-200510000-00006

DO - 10.1097/00019501-200510000-00006

M3 - Article

C2 - 16205454

AN - SCOPUS:27344433839

VL - 16

SP - 451

EP - 456

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 7

ER -